Previous Page  70 / 490 Next Page
Information
Show Menu
Previous Page 70 / 490 Next Page
Page Background

68

SCIENTIFIC PROGRAMME

| PROGRAMME AND EXHIBITION GUIDE

SATURDAY 30 APRIL 2016

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

11:25 > A radiation dose-response relationship for risk of heart failure in

survivors of Hodgkin lymphoma

B.M.P. Aleman (The Netherlands), F.A. Van Nimwegen, G. Ntentas,

S.C. Darby, M. Schaapveld, M. Hauptmann, P.J. Lugtenburg, C.P.M. Janus,

A.D.G. Krol, F.E. Van Leeuwen, D.J. Cutter

OC-0059

11:35 > Cardiac risk prediction: Moving beyond a mean heart dose model?

M. Maraldo (Denmark), F. Giusti, I. Vogelius, M. Lundemann, S. Bentzen,

M. Van der Kaaij, B. Aleman, M. Henry-Amar, P. Meijnders, E. Moser,

C. Fortpied, L. Specht

OC-0060

Proffered Papers

BRACHYTHERAPY 1: PROSTATE

10:45 - 11:45 | ROOM 4

Chair: F.A. Siebert (Germany)

Chair: R. Alonzi (UK)

10:45 > Focal Brachytherapy: what dose to what volume?

A. Haworth (Australia), H. Reynolds, M. DiFranco, Y. Sun, D. Wraith,

S. Williams, B. Parameswaran, C. Mitchell, M. Ebert

OC-0061

10:55 > High-dose-rate HDR boost for localized prostate cancer decreases long

term rectum toxicity

S. Aluwini (The Netherlands), M. Hoogeman, J. Lebesque, C. Bangma,

L. Incrocci, W. Heemsbergen

OC-0062

11:05 > Real-time in-vivo dosimetry in HDR prostate brachytherapy

J. Mason, B. Al-Qaisieh, A. Henry, P. Bownes (UK)

OC-0063

11:15 > A prediction model for biochemical failure after salvage Iodine-125

prostate brachytherapy

M. Peters (The Netherlands), J.R.N. Van der Voort van Zyp, M.A. Moerland,

C.J. Hoekstra, S. Van de Pol, H. Westendorp, M. Maenhout,

R. Kattevilder, H.M. Verkooijen, P.S.N. Van Rossum, H.U. Ahmed,

T. Shah, M. Emberton, M. Van Vulpen

OC-0064

11:25 > Risk of second malignancies after seed prostate brachytherapy as

monotherapy in a single institution

A. Fernandez Ots (Australia), J. Bucci, D. Malouf, L. Browne, Y. Chin

OC-0065